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Background: Body mass index (BMI) and serum 25-hydroxy vitamin D3 (25OHD) concentrations are inversely related.
As BMI contains only limited information regarding body fat distribution, we aimed to analyze the cross-sectional
associations of abdominal visceral or subcutaneous adipose tissue, next to common adiposity measures, with the
25OHD concentration.
Methods: Data were obtained from three cohorts of two large epidemiological studies in the northeast of Germany
(Study of Health in Pomerania, SHIP-1 and SHIP-Trend), and in Denmark (Health2006). The study populations included
adult men and women from the general population (N = 3072 SHIP-1, N = 803 SHIP-Trend, N = 3195 Health2006).
Visceral and subcutaneous adipose tissue were quantified by magnetic resonance imagining (SHIP-Trend) or ultrasound
(Health2006). Common adiposity measures, including BMI, waist circumference, waist-to-hip ratio, waist-to-height ratio,
body surface area, and body fat percentage were determined by standardized methods in SHIP-1 and Health2006.
Results: The average study participant was overweight (median BMI 27.4, 26.6, and 25.2 kg/m2 in SHIP-1, SHIP-Trend,
and Health2006, respectively). Visceral and subcutaneous adipose tissue as well as the common adiposity measures
were inversely associated with serum 25OHD concentrations in linear regression models adjusted for age, sex, alcohol
consumption, physical activity, smoking status, and month of blood sampling.
Conclusions: Next to common adiposity measures, also abdominal visceral or subcutaneous adipose tissue are
inversely associated with serum 25OHD concentrations in the general adult population.
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The classical function of vitamin D in human metabolism
is to regulate calcium absorption in the duodenum and
reabsorption in the kidney [1]. Vitamin D is consumed
either through diet or produced directly in the skin after
exposure to sunlight [2]. It is fat-soluble and adipose
tissue is its major storage site [2, 3]. In the last years,
several studies, e.g. [4–6], demonstrated that obese indi-
viduals have lower circulating vitamin D concentrations
than non-obese individuals. A meta-analysis [7] confirmed
these findings; there was a statistically significant inverse
association between the body mass index (BMI) and
serum 25-hydroxy vitamin D3 (25OHD) concentrations.* Correspondence: anke.hannemann@uni-greifswald.de
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creativecommons.org/publicdomain/zero/1.0/Recently, a study using a Mendelian randomization ap-
proach suggested a causal relation between BMI and
serum 25OHD concentrations [8]. In that study [8], twelve
BMI-related single nucleotide polymorphisms (SNPs) and
four 25OHD-related SNPs (two related to 25OHD synthe-
sis and two related to 25OHD metabolism) were analysed.
It was demonstrated that an increase in BMI leads to a
linear reduction in serum 25OHD concentrations. On the
other hand, there was no evidence for a regulation of BMI
by 25OHD concentrations [8]. The mechanism underlying
this observation is not fully investigated yet. One possible
explanation for the observed causal relation might be that
vitamin D bioavailability is reduced in obesity due to an
increased uptake in adipose tissue [9].
In clinical practice, the easiest and most convenient way
to assess obesity and overweight is to determine BMI and
waist circumference. Yet, these measures contain onlyess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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importance, as visceral adipose tissue (VAT) better reflects
metabolic and cardiovascular risk than subcutaneous adi-
pose tissue (SAT) [10, 11]. Up to now, inverse associations
between VAT or SAT and plasma 25OHD concentrations
have been reported from a family study including Hispanic
and African-Americans [12] and from Canadian residents
with European or South Asian ancestry [13]. Moreover,
inverse associations between VAT or SAT and serum
25OHD concentrations have been reported from the
Framingham Heart Study [14], including 1882 Third
Generation participants. While these three studies [12–14]
investigated CT-based VAT or SAT, data on MRI-based
SAT or VAT is sparse. Moreover, most previous studies
assessing the association between common adiposity mea-
sures as BMI [5–7, 15], waist circumference [6, 15], waist-
to-hip ratio [15, 16], waist-to-height ratio [17], body fat
[18, 19] or body surface area [20], focus on the association
between one or two selected adiposity measures. In the
present study we aimed to assess a comprehensive panel
of eight adiposity measures with serum 25OHD concen-
trations from three cohorts of two large epidemiological
studies. These adiposity measures include abdominal VAT
or SAT, body fat percentage (%bodyfat), BMI, waist cir-
cumference, waist-to-hip ratio, waist-to-height ratio and
the body surface area.
Methods
Study populations
Data was obtained from the Study of Health in Pomerania
(SHIP-1 and SHIP-Trend, conducted in the northeast of
Germany) and Health2006 (conducted in Denmark). All
investigations were carried out in accordance with the
Declaration of Helsinki, including written informed con-
sent of all participants. The survey and study methods of
both studies were approved by institutional review boards
[SHIP-1 (III UV 73/01) and SHIP-Trend (BB 39/09): ethics
committee of the University of Greifswald; Health2006:
Ethical Committee of Copenhagen County (KA-20060011)
and the Danish Data Protection Agency]. In addition,
Health2006 was registered at www.clinicaltrials.gov
(Unique ID: KA20060011).
SHIP-1 and SHIP-Trend
SHIP-1 is the first five-year follow-up of the population-
based SHIP-0 cohort. In the baseline examination be-
tween 1997 and 2001, a total of 4308 men and women
between 20 and 79 years of age participated (response
68.8 %). Out of the 4308 participants, 3300 were re-
examined in SHIP-1 between 2002 and 2006. SHIP-
Trend is a second population-based cohort in the same
study region. In the SHIP-Trend baseline examination
between 2008 and 2012, a total of 4420 men and women
between 20 and 79 years of age participated (response50.1 %). Details on sampling methods and study protocols
have been reported previously [21, 22]. 25OHD concen-
trations were measured in all SHIP-1 and a subsample of
the SHIP-Trend participants. The SHIP-Trend subsample
consisted of the first 1000 study participants without
diabetes mellitus. It is thus not truly representative for
the whole study population as the subjects included are
on average healthier than the whole study population.
Interview and physical examination
All participants underwent standardized medical examina-
tions, blood sampling, and an extensive computer-aided
personal interview. Data on socio-demographic character-
istics and medical histories were collected. Intake of medi-
cation was recorded and classified using the anatomical
therapeutic chemical classification system (ATC). Partici-
pants were defined as physically active, if they reported
any physical activity (SHIP-1) or more than one hour of
physical activity during summer and winter (SHIP-Trend).
During the physical examination, standardized measure-
ments of body height and weight were performed with
calibrated scales. Waist circumference and hip circumfer-
ence were measured using an inelastic tape with the sub-
ject standing comfortably with weight distributed evenly
on both feet. Waist circumference was measured midway
between the lower rib margin and the iliac crest in the
horizontal plane. Hip circumference was determined as
the greatest circumference between the highest point of
the iliac crest and the crotch. BMI was calculated as
weight (kg)/height2 (m2). Waist-to-hip ratio and waist-to-
height ratio were calculated from the respective measures.
Body surface area was calculated according to the for-
mula of DuBois [23]. Additionally, all SHIP-Trend par-
ticipants were offered a body impedance analysis (BIA).
BIA analyses were performed using a Nutriguard M device
and NutriPlus software (Data Input GmbH, Darmstadt,
Germany). Charges of 5 kHz, 50 kHz, and 100 kHz were
applied to measure resistance, reactance and phase angle.
Body fat was automatically calculated from the latter
measurements within the NutriPlus software. Abdominal
VAT and SAT were measured in SHIP-Trend by magnetic
resonance imaging (MRI). The MRI was performed on a
1.5-Tesla system (Magnetom Avanto, Siemens Healthcare
AG, Erlangen, Germany, software version syngo MR B15),
using a body phased-array coil. For the determination of
abdominal fat, axial 3D datasets using the 2-point Dixon
technique were acquired (matrix: 256 × 176; slice thick-
ness 4 mm/4 mm/3 mm without gap; 3 × 64 slices; in-
phase: TE 4.76 ms, TR 7.48 ms; opp-phase: TE 2.38 ms,
TR 7.48 ms). The quantification of abdominal VAT and
SAT was done using ATLAS (automatic tissue and label-
ing analysis software), an in-house developed software at
the University of Ulm. The software first performs a fully-
automated step [24] followed by a manual correction of
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medical students, included setting the upper (left dia-
phragm) and lower border (bladder) for the abdominal fat
analysis, correcting misclassified fat labels and removing fat
labels that do not belong to the abdomen (i.e. arms, breast
fat and parenchyma, bone marrow of pelvis and spine).
Laboratory measurement
Blood samples were taken from the cubital vein of par-
ticipants in the supine position. In SHIP-1, participants
were mostly non-fasting and blood sampling was per-
formed throughout the day. In SHIP-Trend, participants
were fasting and blood sampling was performed between
7.30 a.m. and 1.00 p.m.. Serum 25OHD and serum PTH
concentrations were measured on the IDS-iSYS Multi-
Discipline Automated Analyser (Immunodiagnostic Sys-
tems Limited, Frankfurt am Main, Germany). Serum
25OHD concentrations were measured with the IDS-iSYS
25-Hydroxy Vitamin D assay. The limits of detection and
quantitiation were 3.6 and 5.5 ng/ml, respectively. For
each analyte three concentrations of control material were
measured. In SHIP-1, the coefficients of variation were
16.8 % at low, 13.9 % at medium, and 12.0 % at high
concentrations of control material. In SHIP-Trend, the
coefficients of variation were 11.6 % at low, 9.1 % at
medium, and 10.6 % at high concentrations of control
material. Serum creatinine levels were determined with
a modified kinetic Jaffé method (SHIP-1: Siemens Dimen-
sion RxL; Siemens Healthcare Diagnostics, Eschborn,
Germany; SHIP-Trend: Dade Behring Inc, Newark, USA).
The eGFR was calculated according to the Cockcroft-
Gault formula [25].
Health2006
The Health2006 study is a population-based cross-
sectional study conducted at the Research Centre for
Prevention and Health (RCPH). The methodology of the
study design has been described previously [26]. Study
participants were recruited between June 2006 and May
2008 through the Danish Civil Registration office as a
random sample of men and women aged 18–69 years
living in the western area of the Capital Region of
Denmark. Of 7770 persons invited 3471 participated
corresponding to a participation proportion of 44.7 %.
Interview and physical examination
Health2006 participants underwent standardized medical
examinations, blood sampling, and answered an extensive
questionnaire on lifestyle factors and general health. Par-
ticipants were defined as physically active, if they reported
regular sport and exercise or heavy gardening at least
three times a week or athletic training. Height and weight
were measured wearing light clothes and no shoes. Waist
circumference was measured directly on the body surfacemidway between the lower rib margin and the iliac
crest. The hip circumference was measured over light
clothing at the widest girth of the hip. BMI was calcu-
lated as weight (kg)/height2 (m2). Waist-to-hip ratio and
waist-to-height ratio were calculated from the respective
measures. Body surface area was calculated according to
the formula of DuBois [23]. Additionally, all participants
underwent measurement of impedance for determin-
ation of %bodyfat and intra-peritoneal fatness (assessed
by ultrasound). Ultrasound measures were performed
with the participants lying on their back. VAT was the
distance in cm to two decimals between the posterior
edge of the abdominal muscles and the front of the lumbar
spine. SAT was the distance in cm to two decimals between
the front edge of the abdominal muscles and the skin. All
ultrasound measures were made after a quiet expiration as
described by Stolk et al. [27] with Aquila Pie Medical
(Esaote Europe, Maastricht, The Netherlands). The ultra-
sound measures have been validated against CT/MRI [28].
Fat percentage was measured using a foot-to-foot Tanita
Body Composition Analyzer (TBF-300, TANITA Corpor-
ation of America, Inc., IL, USA).
Laboratory measurement
Fasting venous blood samples from all participants were
taken from the cubital vein of participants in the supine
position. Serum 25OHD and serum PTH concentrations
were measured on the Cobas e411 (Roche Diagnostics
GmbH, Mannheim, Germany). Serum 25OHD concen-
trations were measured with the Vitamin D3 (OH) assay.
The limit of detection was 4.0 ng/ml. For each analyte
three concentrations of control material were measured.
The coefficients of variation were 18.3 % at low, 12.3 %
at medium, and 12.0 % at high concentrations of control
material. Serum creatinine levels were determined with a
modified kinetic Jaffé method (Siemens Healthcare Diag-
nostics, Eschborn, Germany). The eGFR was calculated
according to the Cockcroft-Gault formula [25].
Exclusions
For the present analyses all subjects with missing in-
formation on serum 25OHD concentration (SHIP-1:
n = 63; SHIP-Trend: n = 3425; Health2006: n = 62), on
adiposity measures (SHIP-1: n = 10; SHIP-Trend: n = 133;
Health2006: n = 56) or confounders (SHIP-1: n = 12;
SHIP-Trend: n = 7; Health2006: n = 131) were excluded.
Moreover, we excluded all SHIP participants, who re-
ported intake of prescribed vitamin D preparations or
parathyroid hormone (SHIP-1: n = 25; SHIP-Trend:
n = 7; in Health2006 this information was unavailable),
all subjects with suspected hyperparathyroidism, de-
fined as PTH >120 pg/ml, or missing PTH concentra-
tions (SHIP-1: n = 29; SHIP-Trend: n = 7; Health2006:
n = 4), with a history of liver disease, extreme alcohol
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disease or alcohol consumption (SHIP-1: n = 67; SHIP-
Trend: n = 38; Health2006: n = 8), with renal insufficiency,
defined as eGFR <30 ml/min or missing creatinine concen-
trations (SHIP-1: n = 10; SHIP-Trend: n = 0; Health2006:
n = 15), and all pregnant women (SHIP-1: n = 12; SHIP-
Trend: n = 0; Health2006: n = 0). This resulted in study
populations of 3072 SHIP-1, 803 SHIP-Trend, and 3195
Health2006 participants.
Statistical analyses
As 25OHD concentrations were measured with different
laboratory methods in SHIP and Health2006, the ana-
lyses were performed separately for each study. The
associations between abdominal VAT, SAT or %bodyfat
and 25OHD concentrations were assessed in SHIP-
Trend and Health2006. The associations between BMI,
waist circumference, waist-to-hip ratio, waist-to-height
ratio, or body surface area and 25OHD concentrations
were assessed in SHIP-1 and Health2006. Continuous
data are expressed as median (1st-3rd quartile), nominal
data as percentage.
Multivariable linear regression analyses were performed
to assess the associations of the adiposity measures (ex-
posure) with serum 25OHD concentration (outcome).
The adiposity measures entered the models either catego-
rized in sex-specific quintiles or as continuous variables.
We report adjusted mean 25OHD concentrations with
95 % confidence intervals according to quintiles of adipos-
ity measures as well as ß-coefficients with standard errors
and p-values for a one unit increase in the adiposity mea-
sures. As the association between %bodyfat and serum
25OHD concentration appeared to be non-linear in
Health2006, we included %bodyfat as linear and as quad-
ratic term in the regression model. To address confound-
ing, we adjusted all models for sex, age (years), alcohol
consumption (g/day), physical activity (yes/no), smoking
status (non smoker, ex-smoker, occasional smoker, regular
smoker), and month of blood sampling. P-values <0.05
were considered statistically significant. All statistical ana-
lyses were performed with SAS 9.1 (SAS Institute Inc.,
Cary, NC, USA).
Results
In SHIP-Trend and Health2006 subjects were on average
50 years of age, while subjects in SHIP-1 were older with a
median age of 54 years (Table 1). Women were slightly
overrepresented in all three study populations. Population-
based differences in lifestyle and health-related behaviour
were observed between northeast Germany and Denmark.
Danish adults drank on average more alcohol per day and
had a higher proportion of risky alcohol consumption. In
contrast, German adults had a higher BMI and were
more often obese than Danish adults. The median%bodyfat was barley below 30 % in SHIP-Trend and
Health2006. SHIP-Trend participants had on average 3.1
and 7.0 l, MRI-based abdominal VAT and SAT, respect-
ively. Health2006 participants had on average 2.8 and
5.9 cm abdominal VAT and SAT layers, respectively.
Adjusted mean 25OHD concentrations decreased across
sex-specific quintiles of abdominal VAT or SAT (Fig. 1).
Similar to abdominal VAT and SAT, the adjusted mean
25OHD concentration decreased across quintiles of BMI,
waist circumference, waist-to-hip ratio, waist-to-height
ratio and body surface area (Fig. 2). In fully-adjusted linear
regression models the inverse associations between the
adiposity measures and serum 25OHD concentration
were confirmed (Table 2). For example, we observed
that a 1 l increase in VAT was associated with a decrease
in the 25OHD concentration of 0.58 ng/ml.
When abdominal VAT and SAT were entered in a sin-
gle model only SAT remained statistically significantly
associated with the 25OHD concentration in SHIP-
Trend [ß-coefficient (p-value) for SAT: −0.25 (<0.01); ß-
coefficient (p-value) for VAT: 0.07 (0.77)]. After further
adjustment of the model for BMI, SAT still remained
significant [ß-coefficient (p-value) for SAT: −0.58 (0.01)
ß-coefficient (p-value) for VAT: 0.05 (0.85)]. Regarding
the Health2006 cohort, both VAT and SAT remained sig-
nificant when entered in a single model [ß-coefficient
(p-value) for SAT: −0.24 (0.045); ß-coefficient (p-value)
for VAT: −0.51 (<0.01)]. After further adjustment for BMI,
VAT still remained significant [ß-coefficient (p-value) for
SAT: −0.09 (0.54) ß-coefficient (p-value) for VAT: −0.39
(<0.01)].
In addition, there appeared to be a non-linear associ-
ation between %bodyfat and the 25OHD concentration
in Health2006 (Fig. 1). This association was confirmed
when %bodyfat entered the model as linear and quad-
ratic term.
Discussion
The present cross-sectional study revealed inverse asso-
ciations between abdominal VAT or SAT and serum
25OHD concentrations in general adult populations
from northeast Germany and Denmark. Moreover, pre-
viously reported inverse associations between common
adiposity measures and serum 25OHD concentrations
were confirmed.
The inverse associations between the adiposity mea-
sures and the 25OHD concentration observed in the
three cohorts were alike, and thus strengthen each other.
Previous studies using CT-based [13, 14] or MRI-based
VAT and SAT [18] reported similar results. For example,
in 182 European and 188 South Asian subjects [13],
VAT and SAT were associated with 25OHD concentra-
tions in women, while in men only SAT was associated
with 25OHD. When VAT, SAT and %bodyfat were
Table 1 Characteristics of the study population
Characteristics SHIP-1 (N = 3072) SHIP-Trend (N = 803) Health2006 (N = 3195)
Male, % 48.7 45.2 45.6
Age, years 54.0 (42.0–66.0) 50.0 (40.0–60.0) 50.0 (40.0–60.0)
Smoking, %
Non smoker 41.6 42.5 42.5
Ex smoker 32.3 36.2 32.2
Occasional smoker 3.5 3.4 3.2
Regular smoker 22.6 17.9 22.1
Physical activity,
Any physical activity 40.1 - -
At least 60 min per week during summer and winter - 51.4 -
Regular exercise or heavy gardening at least 3 times a
week or athletic training
- - 21.4
Risky alcohol consumption, %a 8.7 7.0 22.2
Alcohol, g/day 3.9 (1.0–11.8) 4.2 (1.3–10.5) 10.3 (3.4–22.3)
eGFR, ml/min 97.6 (77.6–121.6) 106.1 (86.7–128.8) 97.7 (81.8–116.6)
25OHD, ng/ml 17.5 (12.5–24.5) 24.9 (17.7–32.7) 16.7 (11.8–22.3)
25OHD <20 ng/ml, % 59.8 33.0 66.0
PTH, pg/ml 34.1 (25.7–44.4) 31.2 (23.8–39.4) 39.0 (30.5–36.1)
VAT (MRI), l - 3.1 (1.6–5.1) -
VAT (ultrasound), cm - - 5.9 (4.6–7.8)
SAT (MRI), l - 6.9 (5.2–9.4) -
SAT (ultrasound), cm - - 2.8 (2.1–3.7)
Bodyfat, % - 28.0 (22.8–33.9) 29.1 (22.9–36.1)
BMI, kg/m2 27.4 (24.4–30.8) 26.6 (23.8–29.5) 25.2 (22.2–28.1)
BMI <25 kg/m2 29.3 35.1 48.2
BMI 25–29 kg/m2 40.8 43.0 36.7
BMI 30–39 kg/m2 28.1 21.4 14.1
BMI ≥40 kg/m2 1.9 0.5 1.0
Waist circumference, cm 92.2 (82.5–102.0) 86.5 (77.6–96.0) 88.0 (78.0–97.0)
Waist-to-hip ratio 0.86 (0.81–0.93) 0.86 (0.80–0.93) 0.87 (0.80–0.94)
Waist-to-height ratio 0.55 (0.49–0.60) 0.51 (0.46–0.56) 0.51 (0.46–0.56)
Body surface area, m2 1.89 (1.74–2.04) 1.89 (1.74–2.03) 1.89 (1.73–2.04)
Data are median (1st – 3rd quartile) or proportions
BMI body mass index, eGFR estimated glomerular filtration rate according to the Cockcroft-Gault formula, MRI magnetic resonance imaging, PTH parathyroid hor-
mone, SAT abdominal subcutaneous adipose tissue, VAT visceral adipose tissue, 25OHD 25-hydroxy vitamin D
adefined as ≥30 g/day in men and ≥20 g/day in women
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25OHD concentrations in both sexes [13]. In another
study including 1882 Framingham Third Generation
participants [14], VAT and SAT were both associated
with 25OHD concentrations. After adjustment for waist
circumference or when VAT and SAT entered the same
model, only VAT remained associated with 25OHD [14].
In 567 Chinese men VAT and SAT correlated signifi-
cantly with 25OHD concentrations in unadjusted ana-
lysis [18]. In multivariable linear regression modelsadjusted for BMI, VAT but not SAT was significantly in-
verse associated with 25OHD concentrations [18].
Moreover, in 60 postmenopausal women [29], the pre-
diction of MRI-based VAT improved after including the
25OHD concentration and four further biomarkers in a
model consisting of age, ethnicity, BMI, waist circumfer-
ence, and waist-to-hip ratio [29]. In the present study
VAT and SAT were both strongly associated with the
25OHD concentration. When VAT, SAT and BMI were
entered in a single model only VAT (Health2006) or
Fig. 1 Association between 25-hydroxy vitamin D (25OHD) and adipose tissue. Legend: Adjusted mean serum 25-hydroxy vitamin D (25OHD)
concentrations with 95 % confidence intervals according to sex-specific quintiles of visceral and subcutaneous adipose tissue (VAT and SAT) measured
by MRI in SHIP-Trend and by ultrasound in Health2006 and of %bodyfat in SHIP-Trend (N = 803) and Health2006 (N = 3195)
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provide no final conclusion on whether VAT or SAT is
more robustly associated with the 25OHD concentration.
As with VAT and SAT previous studies in adolescents
[30], post-menopausal women [19] or men [18], ethnic
diverse populations [13], or obese and non-obese women
[31–33], demonstrated inverse relations between bodyfat
and 25OHD concentrations. These associations were
present irrespective if bodyfat was given as proportion
[13, 18, 30, 32] or as mass [19, 30, 31, 33, 34] and irre-
spective if fat mass was determined by dual X-ray absorp-
tiometry [13, 19, 30, 31, 34] or by body impedance [18, 32,
33]. Inverse linear associations of %bodyfat [13, 18], totalFig. 2 Association between 25-hydroxy vitamin D (25OHD) and standard a
D (25OHD) concentrations with 95 % confidence intervals according to sex-sp
ratio, waist-to-height ratio and body surface area in SHIP-1 (N = 3072) and He[34] or total and regional fat mass [19] with 25OHD con-
centrations were reported from these studies. This is in
agreement with our results: subjects with a high %bodyfat
have lower 25OHD concentration than subjects with a
low %bodyfat.
Moreover, data on the association between total body
surface area and 25OHD concentrations is sparse. To
the best of our knowledge, only one previous study
analyzed this relation in 489 apparently healthy subjects
[20]. The authors found a significant positive relationship
between height, body surface area and the 25(OH)D
concentration. This positive association was explained
with increased synthesis of vitamin D in the skin due todiposity measures. Legend: Adjusted mean serum 25-hydroxy vitamin
ecific quintiles of body mass index, waist circumference, waist-to-hip
alth2006 (N = 3195)
Table 2 Associations of different adiposity measures with the
serum 25-hydroxy vitamin D concentration
Adiposity measures Study ß coefficient Standard error p
VAT SHIP-Trend −0.581 0.174 <0.01
Health2006 −0.552 0.069 <0.01
SAT SHIP-Trend −0.481 0.102 <.001
Health2006 −0.496 0.117 <0.01
%Bodyfat SHIP-Trend −0.266 0.059 <.001
Health2006 0.469a 0.101 <0.01
−0.010b 0.002 <0.01
BMI SHIP-1 −0.253 0.031 <0.01
Health2006 −0.250 0.034 <0.01
Waist circumference SHIP-1 −0.112 0.013 <0.01
Health2006 −0.112 0.013 <0.01
Waist-to-hip ratio SHIP-1 −16.212 2.625 <0.01
Health2006 −14.898 2.370 <0.01
Waist-to-height ratio SHIP-1 −19.270 2.114 <0.01
Health2006 −18.837 2.232 <0.01
Body surface area SHIP-1 −5.090 0.878 <0.01
Health2006 −5.363 0.883 <0.01
ß-coefficients, standard errors, and p-values from fully-adjusted multivariable linear
regression analyses. Effect estimates for a one unit increase in the adiposity
measures were modeled. For example, in SHIP-1 a one kg/m2 increase in BMI
is associated with a decrease in the 25OHD concentration of 0.25 ng/ml. All
models were adjusted for age, sex, smoking status, physical activity, alcohol
consumption, and month of blood sampling
The association between %bodyfat and the 25OHD concentration in
Health2006 is non-linear. Therefore, we included %bodyfat and %bodyfat
squared in the regression model
BMI body mass index, SAT abdominal subcutaneous adipose tissue, VAT
visceral adipose tissue
alinear term
bsquared term
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have higher 25OHD concentrations [20]. Concurrently,
BMI and waist circumference are highly correlated with
body surface area (spearman correlation coefficients in
SHIP-1 for BMI: 0.61, p-value: <0.01, for waist circum-
ference: 0.75; p < 0.01). An increase in BMI or waist cir-
cumference may not be related to an increase in skin
exposure to UV-B radiation. Thus, the inverse associ-
ation between body surface area and the 25OHD con-
centration revealed in the present study also seems to
be plausible.
Previously, several mechanisms underlying the associ-
ation between obesity and vitamin D deficiency have
been proposed. One theory suggests a volumetric dilu-
tion effect [35]. The lipophilic vitamin D3 molecule can
be stored in adipose tissue, leading to a reduced serum
bioavailability [4, 36]. With increasing fat mass, vitamin
D3 is distributed in an increasing mass of adipose tissue
and thus serum bioavailability is reduced [35, 37]. In-
deed, the response to a given UV-B radiation dose islower in obese compared to non-obese subjects [38].
Moreover, vitamin D catabolism may be increased in
obesity, as the 25OHD degrading enzyme CYP24A1 is
increased in obese compared to lean subjects [37]. Other
possible mechanisms explaining the low serum 25OHD
concentrations in obesity include a reduced synthesis of
vitamin D3 in the skin, a smaller skin area exposure to
sunlight, a lack of outdoor activity [36, 39], and a nega-
tive feedback regulation of hepatic 25OHD synthesis
exerted by elevated 1,25-dihydroxy vitamin D and para-
thyroid hormone concentrations [35]. It was thus sug-
gested, that adipose tissue is involved in the regulation
of serum 25OHD concentrations [4].
The present study was performed in a large number of
intensively characterized adults from the general popula-
tion in northeast Germany and Denmark. The size of
the study populations allowed us to determine robust es-
timates for the analyzed associations. Next to these
strengths our study has several limitations that need to
be considered. One limitation is the cross-sectional
study design, which prohibits detecting any causality in
the investigated associations. Yet, a previous study [8]
demonstrated that BMI causally affects the 25OHD con-
centration. We thus speculate that the anthropometry, as
characterized by the different adiposity measures, causally
effects the 25OHD concentration. Another limitation is
the difference in 25OHD measurement and the distinct
VAT or SAT determination (MRI or ultrasound-based),
which prevented us from pooling the data. Moreover,
SHIP and Health2006 participants taking non-prescribed
vitamin D preparations were not excluded from the ana-
lyses. If supplement intake varies between obese and non-
obese subjects, it might cause an under- or overestimation
of the reported effect. Although the intake of non-
prescribed vitamin D preparations was highest in the
lowest BMI quintile it was equal among the four high-
est BMI quintiles in Health2006, therefore we assume
our results to be unaffected. Further, there is no infor-
mation on dietary vitamin D intake in the present
study. Again, differences between obese and non-obese
subjects may have affected our results. A last limitation
of our study is that all analyses are based on single-
occasion 25OHD measurements, which were taken
throughout the year.
Conclusion
Taken together, our study suggests that next to standard
adiposity measures, also MRI or ultrasound-based abdom-
inal VAT or SAT are inversely associated with the 25OHD
concentration. The associations between the adiposity
measures and the 25OHD concentration were strikingly
similar between northeast Germany and Denmark despite
differences in lifestyle and despite different methods of
adipose tissue quantification.
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